Kojima Noriaki, Yonemura Yutaka, Bando Etsuro, Morimoto Kouji, Kawamura Taiichi, Yun Hyo-Yung, Ito Ichiro, Kameya Toru, Hayashi Isamu
Department of Gastrointestinal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
Hepatogastroenterology. 2008 May-Jun;55(84):1112-7.
BACKGROUND/AIMS: Preoperative diagnosis for wall invasion and lymph node metastasis is sometimes difficult in T1 gastric cancer. Optimum dissection extent of lymph nodes for T1 gastric cancer was studied from the aspect of subclassification of wall invasion and lymph node metastasis including micrometastasis.
184 patients with cT1 or pT1 gastric cancer were studied. The grade of clinical wall invasion (cT) and clinical lymph node status (cN) were diagnosed by endoscopy and computed tomography or intraoperative findings. Lymph node metastasis (pN) was studied by hematoxylin and eosin staining and immunohistochemistry (IHC).
In 79 cM tumors, 60 (75.9%) were diagnosed as pM. In 88 cSM tumors, 42 (47.7%) were diagnosed as pSM. In 94 pM gastric cancers, micrometastases were found in two patients (2.1%) and in N1 stations. Two (1.9%) of 70 pSM cancers had micrometastasis in No. 7, 8a and 12a stations. Lymph node metastasis (pN) correlated significantly with the depth of tumor invasion, lymphatic invasion and venous invasion. Regarding the pN2 stations, one (1.1%) of 94 pM tumors had lymph node metastasis in No.7 station, and 9 (12.9%) of 70 pSM tumors had nodal involvement in No.7, 8a, 11p, 12a and 14v stations. All eight pN+/cM tumors were diagnosed as nN0 and four (1.4%) of 23 pN+/cSM tumors were correctly diagnosed as pN+. In contrast, 8 (9.9%) of 81 cN0/cM tumors and 19 (24.1%) of 79 cN0/cSM tumors had histological lymph node metastasis (pN+).
Accuracy of the clinical diagnosis of lymph node metastasis is very low. Accordingly, prophylactic lymph node dissection is recommended even for cT1 and cN0 tumors. For cN0/cM cancer, D1+No.7 is recommended. D1+No.7, 8a, 9, 11p is recommended for cSM cancer, located in U or M region and additional dissection of No. 14v is recommended for cSM cancer located in L region.
背景/目的:T1期胃癌术前诊断壁侵犯和淋巴结转移有时存在困难。从壁侵犯和淋巴结转移的亚分类包括微转移方面研究T1期胃癌淋巴结的最佳清扫范围。
对184例cT1或pT1期胃癌患者进行研究。临床壁侵犯分级(cT)和临床淋巴结状态(cN)通过内镜检查、计算机断层扫描或术中所见进行诊断。淋巴结转移(pN)通过苏木精-伊红染色和免疫组织化学(IHC)进行研究。
在79例cM期肿瘤中,60例(75.9%)被诊断为pM期。在88例cSM期肿瘤中,42例(47.7%)被诊断为pSM期。在94例pM期胃癌中,2例患者(2.1%)在N1站发现微转移。70例pSM期癌中有2例(1.9%)在第7、8a和12a站有微转移。淋巴结转移(pN)与肿瘤侵犯深度、淋巴管侵犯和静脉侵犯显著相关。关于pN2站,94例pM期肿瘤中有1例(1.1%)在第7站有淋巴结转移,70例pSM期肿瘤中有9例(12.9%)在第7、8a、11p、12a和14v站有淋巴结受累。所有8例pN+/cM期肿瘤均被诊断为nN0,23例pN+/cSM期肿瘤中有4例(1.4%)被正确诊断为pN+。相比之下,81例cN0/cM期肿瘤中有8例(9.9%)和79例cN0/cSM期肿瘤中有19例(24.1%)有组织学淋巴结转移(pN+)。
淋巴结转移的临床诊断准确性非常低。因此,即使对于cT1和cN0期肿瘤也建议进行预防性淋巴结清扫。对于cN0/cM期癌,建议行D1+第7站清扫。对于位于U或M区的cSM期癌,建议行D1+第7、8a、9、11p站清扫,对于位于L区的cSM期癌,建议额外清扫第14v站。